Evidence map›Paper›PMID 35208870›Full record

ArticleMicroorganisms2022

Factors Affecting the Intraluminal Therapy for

Cheng-Yu Ho, Ting-Wen Liu, Yang-Sheng Lin, Yen-Po Chen, Ming-Jen Chen, Horng-Yuan Wang, Tai-Cherng Liou

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Efficacy and Safety of Tegoprazan inPharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Effect of acacetin on inhibition of apoptosis inWorld journal of gastrointestinal oncology · 2024
    Article
  4. Unveiling the Antibacterial Properties of Statins: AnAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  5. Review
  6. Intraluminal Therapy forBiomedicines · 2023
    Article
  7. Detection and Treatment ofGastroenterology research and practice · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Cheng-Yu HoDivision of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Tamsui, New Taipei City 25173, Taiwan.
Ting-Wen LiuDepartment of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
Yang-Sheng LinDepartment of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
Yen-Po ChenDivision of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Tamsui, New Taipei City 25173, Taiwan.
Ming-Jen ChenDepartment of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
Horng-Yuan WangDepartment of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan.
Tai-Cherng LiouDivision of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, Tamsui, New Taipei City 25173, Taiwan.ORCID 0000-0002-6681-3819
Mackay Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acidityendoscopygastric juiceHelicobacter pyloririsk factorstherapy

Identifiers

PMID35208870
PMCPMC8876938
OpenAlexW4210975743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.